CME Group price target raised to $269 from $235 at RBC Capital

RBC Capital analyst Ashish Sabadra raised the firm’s price target on CME Group (CME) to $269 from $235 and keeps a Sector Perform rating on the shares after its Q4 earnings beat. The macro uncertainty and tariffs under the new administration, increased market and rate volatility, and Treasury issuances – along with client growth, particularly in retail expansion – bode well for volume growth, though the firm continues to monitor the tough comparisons, the analyst tells investors in a research note.